Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 3 | 2018 | 200 | 0.340 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 461 | 0.210 |
Why?
|
| Glutathione Disulfide | 1 | 2016 | 2 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 43 | 0.140 |
Why?
|
| Glutathione | 1 | 2016 | 44 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 60 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 146 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 327 | 0.090 |
Why?
|
| Cytarabine | 2 | 2018 | 55 | 0.070 |
Why?
|
| Cell Line | 2 | 2018 | 435 | 0.060 |
Why?
|
| Mice | 2 | 2018 | 2475 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 7466 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2615 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3317 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mitoxantrone | 1 | 2018 | 19 | 0.040 |
Why?
|
| Sulfides | 1 | 2018 | 27 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 41 | 0.040 |
Why?
|
| Caprylates | 1 | 2018 | 28 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2018 | 70 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 104 | 0.040 |
Why?
|
| Recurrence | 1 | 2018 | 265 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 154 | 0.040 |
Why?
|
| Biopsy | 1 | 2018 | 260 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 456 | 0.030 |
Why?
|
| Mitochondria | 1 | 2018 | 186 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 100 | 0.030 |
Why?
|
| RNA Stability | 1 | 2015 | 4 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 268 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 39 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 30 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 52 | 0.030 |
Why?
|
| Idarubicin | 1 | 2014 | 7 | 0.030 |
Why?
|
| Boronic Acids | 1 | 2014 | 8 | 0.030 |
Why?
|
| Pyrazines | 1 | 2014 | 13 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 34 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2016 | 231 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 248 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 196 | 0.030 |
Why?
|
| Humans | 4 | 2018 | 32024 | 0.030 |
Why?
|
| Male | 3 | 2018 | 19195 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2014 | 134 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 335 | 0.030 |
Why?
|
| Female | 3 | 2018 | 19953 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 508 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 734 | 0.030 |
Why?
|
| Aged | 2 | 2018 | 10340 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 629 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 835 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 370 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1061 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 1067 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 1269 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2441 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4000 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3526 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 9366 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 11868 | 0.010 |
Why?
|